We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300408:SZSEChaozhou Three-Circle (Group) Co., Ltd. Class A Analysis

Data as of 2026-07-22 - not real-time

CN¥102.98

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Revenue surged 46% YoY and the company posted a healthy gross margin of 42% and operating margin of 34%, supported by a cash pile of over CNY 6.6 bn and modest debt. However, the stock trades at a PE of 69x—more than double the industry average of 34x—and the discounted cash‑flow model values it at roughly CNY 31, implying a significant overvaluation relative to fundamentals. Technicals show the price sitting below the 20‑day and 50‑day SMAs, a bearish MACD histogram, and an RSI around 39, suggesting limited upside in the near term despite a computed bullish trend direction. Volatility is extreme at over 117% 30‑day, though beta is modest, and the dividend yield is low at 0.42% with a comfortable payout ratio of 25%.
Given the strong cash generation, low leverage and sustainable dividend, the company’s fundamentals remain solid, but the market price appears stretched. Investors should weigh the growth narrative against the valuation gap and heightened price swings, positioning the stock more as a hold or short‑term sell until valuation aligns with earnings potential.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD and RSI indicating near‑term weakness
  • Current price well above support but below key moving averages
  • Extreme short‑term volatility increasing downside risk

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth and robust operating margins
  • Sustained cash flow generation supporting dividend and debt servicing
  • Valuation still elevated, requiring price correction before upside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Long‑term demand for electronic ceramic components in expanding tech segments
  • Solid balance sheet with low leverage and ample liquidity
  • Overvaluation relative to DCF fair value suggests limited upside without earnings acceleration

Key Metrics & Analysis

Financial Health

Revenue Growth46.30%
Profit Margin29.19%
P/E Ratio69.1
ROE13.43%
ROA6.78%
Debt/Equity2.53
P/B Ratio8.8
Op. Cash FlowCN¥2.8B
Free Cash FlowCN¥1.5B
Industry P/E33.8

Technical Analysis

TrendBullish
RSI39.2
SupportCN¥86.03
ResistanceCN¥180.35
MA 20CN¥132.48
MA 50CN¥128.16
MA 200CN¥72.19
MACDBearish
VolumeStable
Fear & Greed Index90.46

Valuation

Fair ValueCN¥30.99
Target PriceCN¥99.00
Upside/Downside-3.86%
GradeOvervalued
TypeGrowth
Dividend Yield0.42%

Risk Assessment

Beta0.61
Volatility117.80%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.